A Retrospective study of complications of therapeutic plasma exchange in myasthenia

被引：25

作者：

Guptill, Jeffrey T. ^{[1
]}

Oakley, Darlene ^{[2
]}

Kuchibhatla, Maragatha ^{[3
]}

Guidon, Amanda C. ^{[1
]}

Hobson-Webb, Lisa D. ^{[1
]}

Massey, Janice M. ^{[1
]}

Sanders, Donald B. ^{[1
]}

Juel, Vern C. ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Duke Therapeut Apheresis Serv, Durham, NC 27710 USA

[3] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA

来源：

MUSCLE & NERVE | 2013年 / 47卷 / 02期

关键词：

cohort study; complications; myasthenia gravis; plasmapheresis; plasma exchange; CENTRAL VENOUS CATHETERS; INTRAVENOUS IMMUNOGLOBULIN; GRAVIS; PLASMAPHERESIS; METAANALYSIS; DISORDERS; MULTICENTER; EXPERIENCE; MORBIDITY; DISEASES;

D O I：

10.1002/mus.23508

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

100204 [神经病学];

摘要：

Introduction: Venous access for therapeutic plasma exchange (TPE) in myasthenia gravis (MG) can be achieved by central venous catheters (CVC) or peripheral veins (PV), and the preferred method varies among providers. We evaluated our institutional experience with TPE venous access method and complications. Methods: We reviewed all TPE-treated MG patients (20052010) through blinded chart review. TPE complications were categorized as serious or minor. Serious complications ended the procedure and/or were potentially life-threatening. Results: A total of 134 MG patients received 230 TPE courses; 56% were outpatient procedures. Whenever feasible, TPE was performed by PV access, which was successful in 75% of courses. Over 90% in both groups improved after TPE. Compared with PV access, CVCs were associated with more total (68% vs. 35%) and serious complications (41% vs. 4%), including 2 deaths. Conclusions: PV access for TPE can be used successfully in most MG patients and may reduce morbidity of the procedure. Muscle Nerve 47: 170-176, 2013

引用

页码：170 / 176

页数：7

共 37 条

[1]

Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals [J].

Alshekhlee, A. ;

Miles, J. D. ;

Katirji, B. ;

Preston, D. C. ;

Kaminski, H. J. .

NEUROLOGY, 2009, 72 (18) :1548-1554

[2]

[Anonymous], 1986, JAMA, V256, P1333

[3]

Comparison of IVIg and PLEX in patients with myasthenia gravis [J].

Barth, D. ;

Nouri, M. Nabavi ;

Ng, E. ;

Nwe, P. ;

Bril, V. .

NEUROLOGY, 2011, 76 (23) :2017-2023

[4]

Complications of therapeutic plasma exchange: Experience with 4857 treatments [J].

Basic-Jukic, N ;

Kes, P ;

Glavas-Boras, S ;

Brunetta, B ;

Bubic-Filipi, L ;

Puretic, Z .

THERAPEUTIC APHERESIS AND DIALYSIS, 2005, 9 (05) :391-395

[5]

PLASMA-EXCHANGE MORBIDITY IN GUILLAIN-BARRE-SYNDROME - RESULTS FROM THE FRENCH PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, MULTICENTER STUDY [J].

BOUGET, J ;

CHEVRET, S ;

CHASTANG, C ;

RAPHAEL, JC .

CRITICAL CARE MEDICINE, 1993, 21 (05) :651-658

[6]

Predictors of Complications in Therapeutic Plasma Exchange [J].

Bramlage, Carsten P. ;

Schroeder, Katharina ;

Bramlage, Peter ;

Ahrens, Katharina ;

Zapf, Antonia ;

Mueller, Gerhard Anton ;

Koziolek, Michael J. .

JOURNAL OF CLINICAL APHERESIS, 2009, 24 (06) :225-231

[7]

A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].

CHARLSON, ME ;

POMPEI, P ;

ALES, KL ;

MACKENZIE, CR .

JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383

[8]

COMPLICATIONS OF THERAPEUTIC PLASMA-EXCHANGE - A RECENT ASSESSMENT [J].

COURIEL, D ;

WEINSTEIN, R .

JOURNAL OF CLINICAL APHERESIS, 1994, 9 (01) :1-5

[9]

Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis [J].

Gajdos, P ;

Chevret, S ;

Clair, B ;

Tranchant, C ;

Chastang, C .

ANNALS OF NEUROLOGY, 1997, 41 (06) :789-796

[10]

Grishaber J E, 1992, J Clin Apher, V7, P119, DOI 10.1002/jca.2920070304

← 1 2 3 4 →